Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Chinook Therapeutics Inc KDNY

Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering, developing and commercializing precision medicines for kidney diseases. Its lead product candidate is atrasentan, a potent and selective endothelin A receptor (ET A receptor), antagonist that is developing for the treatment of proteinuric glomerular diseases. Atrasentan is in Phase... see more

Recent & Breaking News (NDAQ:KDNY)

Chinook Shareholder Notice

Newsfile September 12, 2023

Chinook Shareholder Action Reminder

Newsfile September 5, 2023

Chinook Shareholder Notice

Newsfile September 3, 2023

Chinook Shareholder Notice

Newsfile August 29, 2023

Chinook Shareholder Action Reminder

Newsfile August 28, 2023

Chinook Shareholder Notice

Newsfile August 25, 2023

Chinook Shareholder Action Reminder

Newsfile August 24, 2023

Chinook Shareholder Action Reminder

Newsfile August 21, 2023

Chinook Investor Alert

Newsfile August 20, 2023

Chinook Shareholder Notice

Newsfile August 18, 2023

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Chinook Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm

Accesswire August 18, 2023

Chinook Investor Alert

Newsfile August 16, 2023

Chinook Shareholder Notice

Newsfile August 15, 2023

Chinook Investor Alert

Newsfile August 13, 2023

Chinook Shareholder Action Reminder

Newsfile August 10, 2023

Chinook Shareholder Notice

Newsfile August 8, 2023

Chinook Shareholder Action Reminder

Newsfile August 7, 2023

INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Chinook Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm

Accesswire August 5, 2023

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Chinook Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm

Accesswire August 4, 2023

Chinook Shareholder Action Reminder

Newsfile August 3, 2023